Thomas M. Reilly

3.5k total citations
75 papers, 2.7k citations indexed

About

Thomas M. Reilly is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas M. Reilly has authored 75 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 24 papers in Molecular Biology and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas M. Reilly's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Protease and Inhibitor Mechanisms (16 papers) and Platelet Disorders and Treatments (14 papers). Thomas M. Reilly is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Protease and Inhibitor Mechanisms (16 papers) and Platelet Disorders and Treatments (14 papers). Thomas M. Reilly collaborates with scholars based in United States, Sweden and Russia. Thomas M. Reilly's co-authors include Rick C. Sasso, Carl T. Brighton, Theresa O. Scholl, Shaker A. Mousa, Peter Hall, Natalie M. Best, Clark T. Hung, Solomon R. Pollack, Harry L. Walton and Dean G. Lorich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Thomas M. Reilly

75 papers receiving 2.6k citations

Peers

Countries citing papers authored by Thomas M. Reilly

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Reilly more than expected).

Fields of papers citing papers by Thomas M. Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Reilly. The network helps show where Thomas M. Reilly may publish in the future.

Co-authorship network of co-authors of Thomas M. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Reilly. A scholar is included among the top collaborators of Thomas M. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Reilly. Thomas M. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of Operative Complications in a Series of 471 Anterior Lumbar Interbody Fusion Procedures 2005 ·Spine ·Rick C. Sasso, Natalie M. Best, Praveen V. Mummaneni, Thomas M. Reilly, Sajjad Hussain	148
2	Atlantoaxial Stabilization: Clinical Comparison of Posterior Cervical Wiring Technique With Transarticular Screw Fixation 2003 ·Journal of Spinal Disorders & Techniques ·Thomas M. Reilly, Rick C. Sasso, Peter Hall	60
3	A double antibody radioimmunoassay for the determination of XV459, the active hydrolysis metabolite of roxifiban, in human plasma 2002 ·Journal of Pharmaceutical and Biomedical Analysis ·Henry J. Pieniaszek, (unknown), Harry L. Walton, Donald Pinto, Richard E. Olson, Thomas M. Reilly, Yu Chen Barrett	7
4	Anemia, Iron and Pregnancy Outcome 2000 ·Journal of Nutrition ·Theresa O. Scholl, Thomas M. Reilly	200
5	Disposition and exposure of the fibrinogen receptor antagonist XV459 on αIIBβ3 binding sites in the guinea pig 1999 ·Biopharmaceutics & Drug Disposition ·Jeffrey S. Barrett, Jun Yu, Ram P. Kapil, (unknown), Foster Brown, William F. Ebling, Martha H. Corjay, Thomas M. Reilly, Jeffrey M. Bozarth, Shaker A. Mousa, Henry J. Pieniaszek	6
6	Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802 1998 ·Journal of Cardiovascular Pharmacology ·Shaker A. Mousa, Richard E. Olson, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, (unknown), (unknown), (unknown), (unknown), Ram P. Kapil, John Wityak, Thais M. Sielecki, Ruth R. Wexler, Martin Thoolen, Andrew Slee, Thomas M. Reilly, Paul Anderson, Paul A. Friedman	13
7	Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury1: 1997 ·Cardiovascular Research ·Sanjay S. Srivatsa, Lorraine A. Fitzpatrick, (unknown), Thomas M. Reilly, David R. Holmes, Robert S. Schwartz, Shaker A. Mousa	139
8	The Biochemical Pathway Mediating the Proliferative Response of Bone Cells to a Mechanical Stimulus* 1996 ·Journal of Bone and Joint Surgery ·Carl T. Brighton, (unknown), Stuart E. Levine, John R. Corsetti, Thomas M. Reilly, Adam S. Landsman, John L. Williams, Lawrence E. Thibault	97
9	Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs 1994 ·Thrombosis Research ·Shaker A. Mousa, (unknown), William Lorelli, (unknown), (unknown), (unknown), Thomas M. Reilly	8
10	Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites 1993 ·European Journal of Pharmacology Molecular Pharmacology ·(unknown), Thomas J. Mitchell, Thomas M. Reilly, P B Timmermans, P Verroust, (unknown)	4
11	Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GPIIb/llla Receptor Antagonist 1993 ·Cardiology ·Shaker A. Mousa, (unknown), Mark S. Forsythe, William Lorelli, Martin Thoolen, N. Ramachandran, Sharon Jackson, (unknown), Thomas M. Reilly	40
12	Recombinant plasminogen activator inhibitor-1 protects platelets against the inhibitory effects of plasmin 1993 ·Thrombosis Research ·Thomas M. Reilly, Mark S. Forsythe, (unknown), Susan Spitz, Harry L. Walton, Shaker A. Mousa	4
13	A spectroscopic study of the conformations of active and latent forms of recombinant plasminogen activator inhibitor-1 1991 ·Biochemical and Biophysical Research Communications ·Anil M. Dwivedi, (unknown), Harry L. Walton, Thomas M. Reilly	12
14	Inhibition of the thrombin-platelet reactions by DuP 714 1991 ·Biochemical and Biophysical Research Communications ·Andrew T. Chiu, Shaker A. Mousa, Lori J. Pease, (unknown), Jeffrey M. Bozarth, Thomas M. Reilly, Ronald D. Smith, Pieter B.M.W.M. Timmermans	4
15	Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. 1990 ·PubMed ·Richard S. Morrison, Janet L. Gross, William F. Herblin, Thomas M. Reilly, (unknown), (unknown), Joseph R. Moskal, Paul L. Kornblith, Daniel L. Dexter	87
16	Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo 1989 ·Biochemical and Biophysical Research Communications ·Thomas M. Reilly, David S. Taylor, William F. Herblin, Martin Thoolen, Andrew T. Chiu, Dennis W. Watson, Pieter B.M.W.M. Timmermans	70
17	Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Pancras C. Wong, William A. Price, Thomas M. Reilly, John V. Duncia, (unknown)	17
18	Tissue plasminogen activator-induced secretion of type-1 plasminogen activator inhibitor in cultured human fibroblasts 1989 ·Thrombosis Research ·Thomas M. Reilly, (unknown), Pieter B.M.W.M. Timmermans	6
19	Characterization of a Panel of Monoclonal Antibodies Against Human Tissue-Type Plasminogen Activator 1988 ·Hybridoma ·Thomas M. Reilly, (unknown), (unknown), (unknown), P.B.M.W.M. Timmermans	5
20	Characterization of the functional antagonism and antihypertensive activity displayed by a monoclonal antibody to angiotensin II. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas M. Reilly, (unknown), William A. Price, Pieter B.M.W.M. Timmermans	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact